Evaluation of the HIV-infected patient with odynophagia and dysphagia
- C Mel Wilcox, MD
C Mel Wilcox, MD
- Professor of Medicine
- University of Alabama at Birmingham
HIV-infected patients with advanced immunosuppression are at risk for esophagitis, which can be severe, and require hospitalization if the patient cannot swallow any liquids. This topic will address the evaluation of the HIV-infected patient with odynophagia and dysphagia. The treatment of esophageal candidiasis is discussed elsewhere. (See "Treatment of oropharyngeal and esophageal candidiasis".)
RISK FACTORS FOR ESOPHAGITIS
Patients who have not attained immune reconstitution on potent antiretroviral therapy (ART) or who are not taking ART are at risk of developing esophagitis . Patients with a CD4 cell count <100 cells/mm3 are at particularly high risk.
Esophagitis may be due to Candida, herpes simplex virus (HSV), cytomegalovirus (CMV), or aphthous ulcers, although the most common cause is Candida.
HISTORY AND PHYSICAL EXAMINATION
A history of dysphagia or odynophagia should prompt concerns regarding possible esophagitis. Although oropharyngeal thrush often accompanies esophagitis with a positive predictive value of 90 percent , the converse is not always true. In one series, 18 percent of patients with Candida esophagitis did not have oral thrush .
In two prospective studies, Candida esophagitis was detected by endoscopy in up to 64 percent of symptomatic patients [3,4]. If odynophagia rather than dysphagia is the most prominent symptom, candida esophagitis is less probable. The patient with severe odynophagia, without dysphagia or thrush, is more likely to have ulcerative esophagitis, such as herpes simplex virus, rather than Candida species. Rarely, esophageal lymphoma may be diagnosed .To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:
- Mönkemüller KE, Lazenby AJ, Lee DH, et al. Occurrence of gastrointestinal opportunistic disorders in AIDS despite the use of highly active antiretroviral therapy. Dig Dis Sci 2005; 50:230.
- Wilcox CM, Straub RF, Clark WS. Prospective evaluation of oropharyngeal findings in human immunodeficiency virus-infected patients with esophageal ulceration. Am J Gastroenterol 1995; 90:1938.
- Connolly GM, Hawkins D, Harcourt-Webster JN, et al. Oesophageal symptoms, their causes, treatment, and prognosis in patients with the acquired immunodeficiency syndrome. Gut 1989; 30:1033.
- Bonacini M, Young T, Laine L. The causes of esophageal symptoms in human immunodeficiency virus infection. A prospective study of 110 patients. Arch Intern Med 1991; 151:1567.
- Chow DC, B1eikh SH, Eickhoff L, et al. Primary esophageal lymphoma in AIDS presenting as a nonhealing esophageal ulcer. Am J Gastroenterol 1996; 91:602.
- Wilcox CM, Rodgers W, Lazenby A. Prospective comparison of brush cytology, viral culture, and histology for the diagnosis of ulcerative esophagitis in AIDS. Clin Gastroenterol Hepatol 2004; 2:564.
- Wilcox CM. Short report: time course of clinical response with fluconazole for Candida oesophagitis in patients with AIDS. Aliment Pharmacol Ther 1994; 8:347.
- Wilcox CM, Straub RF, Alexander LN, Clark WS. Etiology of esophageal disease in human immunodeficiency virus-infected patients who fail antifungal therapy. Am J Med 1996; 101:599.
- Levine MS. Radiology of esophagitis: a pattern approach. Radiology 1991; 179:1.
- Connolly GM, Forbes A, Gleeson JA, Gazzard BG. Investigation of upper gastrointestinal symptoms in patients with AIDS. AIDS 1989; 3:453.